E-SCIENCE STATION

CASE20230825_011

Anterior STEMI Presenting With Cardiogenic Shock With Apical VSD - Management With ASD Device

By Rohit Mody

Presenter

Rohit Mody

Authors

Rohit Mody1

Affiliation

Mody Harvard Cardiac Institute & Research Centre , India1,
View Study Report
CASE20230825_011
Hemodynamic Support - Hemodynamic Support

Anterior STEMI Presenting With Cardiogenic Shock With Apical VSD - Management With ASD Device

Rohit Mody1

Mody Harvard Cardiac Institute & Research Centre , India1,

Clinical Information

Relevant Clinical History and Physical Exam

65 years old male presented with Acute Anterior wall MI windowperiod- 72hrs NIDDM Hypertensive Presented with Cardiogenic shock ECHO showsapical VSD EF 35% There was sever TR and PAH VSD was showing left to rightshunt with PAH RWMA in Anterior territory. 
1.mp4

Relevant Test Results Prior to Catheterization

NIDDM Hypertensive Presented with Cardiogenic shock ECHO shows apical VSD EF 35% There was sever TR and PAH VSD was showing left to right shunt with PAH RWMA in Anterior territory.

Relevant Catheterization Findings

Angiogram reveals mid LAD 100%, out of window period
1.mp4
2.mp4

Interventional Management

Procedural Step

Angiogram reveals mid LAD 100%, out of window period. IABP was inserted and approached through 6F femoral and 8F internaljugular sheaths. LV entered & VSD crossed and looped in the pulmonary arterysneared through VSD defect into the pulmonary artery, Then ASD device Amplatz 14mmdelivered through 8F sheath, Finally the ASD device was released, and there was noresidual shunt on ECHO, The Patient was stabilized in CCU & IABP was slowlyweaned off in next 4-5 days and discharge ECHO shows no residual shunt andstable hemodynamics
3.mp4
4.mp4

Case Summary

We conclude from this study that VSD device closure insetting ofPost MI is feasible and can be successful as an alternative to surgery. InExtreme cases of hemodynamic instability and shock patient can be taken on MCSlike ECMO. In our case we stabilized the patient with IABP support and an NIVsupport. The most important risk factor for mortality is presence ofcardiogenic shock and closure in acute phase. We did our case at 72 hrs. andpatient was in cardiogenic shock. Percutaneous closure is an option for patients whose comorbiditiespreclude surgical repair and whose septal anatomy is favourable to deviceplacement.